DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,100,736 | +12.1% | 242,244 | +8.4% | 0.31% | +17.7% |
| Q2 2023 | $53,632,320 | -22.8% | 223,468 | -19.0% | 0.26% | -21.8% |
| Q1 2023 | $69,497,762 | -26.8% | 275,741 | -22.9% | 0.34% | -23.8% |
| Q4 2022 | $94,910,211 | -3.6% | 357,585 | -6.2% | 0.44% | -1.1% |
| Q3 2022 | $98,476,000 | +3.2% | 381,261 | +1.3% | 0.45% | +9.2% |
| Q2 2022 | $95,457,000 | +14.5% | 376,527 | +32.5% | 0.41% | +31.6% |
| Q1 2022 | $83,351,000 | +8.6% | 284,155 | +21.8% | 0.31% | +9.1% |
| Q4 2021 | $76,740,000 | +54.5% | 233,245 | +42.9% | 0.29% | +32.3% |
| Q3 2021 | $49,685,000 | -0.7% | 163,201 | -12.5% | 0.22% | -5.2% |
| Q2 2021 | $50,031,000 | +75.7% | 186,431 | +47.4% | 0.23% | +47.7% |
| Q1 2021 | $28,468,000 | +69.5% | 126,479 | +67.3% | 0.16% | +59.8% |
| Q4 2020 | $16,794,000 | -1.1% | 75,599 | -4.2% | 0.10% | -11.0% |
| Q3 2020 | $16,984,000 | +12.0% | 78,874 | -8.1% | 0.11% | +1.9% |
| Q2 2020 | $15,171,000 | -48.1% | 85,797 | -59.4% | 0.11% | -53.3% |
| Q1 2020 | $29,244,000 | +91.6% | 211,286 | +112.4% | 0.23% | +205.3% |
| Q4 2019 | $15,264,000 | +3.1% | 99,454 | -3.0% | 0.08% | -7.4% |
| Q3 2019 | $14,802,000 | +11.1% | 102,488 | +9.9% | 0.08% | +9.5% |
| Q2 2019 | $13,327,000 | +13.8% | 93,245 | +5.2% | 0.07% | +1.4% |
| Q1 2019 | $11,707,000 | +28.8% | 88,673 | +0.6% | 0.07% | +21.7% |
| Q4 2018 | $9,092,000 | +10.5% | 88,172 | +16.5% | 0.06% | +33.3% |
| Q3 2018 | $8,226,000 | -0.5% | 75,703 | -9.7% | 0.04% | -11.8% |
| Q2 2018 | $8,269,000 | +19.1% | 83,793 | +18.2% | 0.05% | +13.3% |
| Q1 2018 | $6,942,000 | +10.7% | 70,894 | +5.0% | 0.04% | +40.6% |
| Q4 2017 | $6,270,000 | +6.0% | 67,545 | -2.1% | 0.03% | -30.4% |
| Q3 2017 | $5,917,000 | +5.5% | 68,977 | +3.8% | 0.05% | +12.2% |
| Q2 2017 | $5,608,000 | +1.4% | 66,449 | +2.7% | 0.04% | -6.8% |
| Q1 2017 | $5,533,000 | +9.5% | 64,688 | -0.4% | 0.04% | +10.0% |
| Q4 2016 | $5,055,000 | -1.9% | 64,937 | -1.2% | 0.04% | +8.1% |
| Q3 2016 | $5,151,000 | -22.3% | 65,707 | +0.1% | 0.04% | -21.3% |
| Q2 2016 | $6,630,000 | +6.5% | 65,642 | +0.0% | 0.05% | +14.6% |
| Q1 2016 | $6,224,000 | +8.9% | 65,617 | +6.7% | 0.04% | +13.9% |
| Q4 2015 | $5,714,000 | +4.1% | 61,525 | -4.5% | 0.04% | -5.3% |
| Q3 2015 | $5,487,000 | -0.4% | 64,395 | +0.0% | 0.04% | +11.8% |
| Q2 2015 | $5,510,000 | -4.3% | 64,375 | -5.1% | 0.03% | -5.6% |
| Q1 2015 | $5,760,000 | +3.5% | 67,845 | +4.5% | 0.04% | -2.7% |
| Q4 2014 | $5,566,000 | +9.4% | 64,937 | +0.5% | 0.04% | +15.6% |
| Q2 2014 | $5,086,000 | +13.0% | 64,600 | +7.7% | 0.03% | +10.3% |
| Q1 2014 | $4,500,000 | -2.8% | 60,000 | 0.0% | 0.03% | 0.0% |
| Q4 2013 | $4,632,000 | +11.4% | 60,000 | 0.0% | 0.03% | +11.5% |
| Q3 2013 | $4,159,000 | +9.5% | 60,000 | 0.0% | 0.03% | +4.0% |
| Q2 2013 | $3,798,000 | – | 60,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |